News

Email is not displaying correctly? View it in your browser.  
 
 
December 20, 2021
 
 
 

When the National Cancer Act was signed on Dec. 23, 1971, it infused record amounts of federal dollars into research labs around the country —and helped transform cancer prevention, detection, diagnosis, treatment, and survivorship. Current and former Winship leaders reflect on the 50 years of progress since the act was signed and how it has made a difference in the lives of people affected by cancer.
Read More
 
 
 
     
 
 
Winship research contributes to FDA approval of first-ever drug for acute GVHD
The Food and Drug Administration on Dec. 15 approved the first-ever drug to be used for the prevention of acute graft versus host disease in adult and pediatric patients, opening the door for safer bone marrow and blood stem cell transplants in patients who do not have a perfectly matched graft donor.
Read More
 
  
Video: Happy holidays from Winship
Winship leadership team members Sagar Lonial, MD, Kimberly Kerstann, PhD, Adam Marcus, PhD, Lana Uhrig, PhD, and Suresh Ramalingam, MD, take a moment to wish the Winship community a healthy and happy holiday season and to thank teams for their contributions to another year of extraordinary contributions to patient care, research, and education.
Watch Video
 
 
 
     
 
 
Harvey receives Fulbright Specialist Award
R. Donald Harvey, PharmD, has received a Fulbright Specialist Award in support of his collaboration with Nigeria's Project PINK BLUE. As a part of this effort, Harvey spent two weeks in Nigeria in early December meeting with partners and participating in training oncology pharmacists.
Read More
 
  
Schneider named director of Cancer Tissue and Pathology
Frank Schneider, MD, has been named director of Winship's Cancer Tissue and Pathology Shared Resource. Schneider has served as interim director of the core facility, which provides high-quality specimens and comprehensive histopathologic services for cancer research.
About the Shared Resource
 
 
 
     
 
 
Bostick to retire
Roberd "Robin" Bostick, MD, MPH, professor of epidemiology at Rollins School of Public Health, will retire on Dec. 31 after nearly two decades at Emory. Bostick helped establish Winship's Cancer Prevention and Control Program and served as the program’s leader for eight years until 2015. His research focused on diet and cancer and was supported by more than $53 million in research grants.
View Profile
 
  
‘Your Fantastic Mind’ episode to focus on long COVID, becoming a brain surgeon
The next episode of “Your Fantastic Mind,” the Emory Brain Health Center’s Emmy award-winning television partnership with Georgia Public Broadcasting, will air on Jan. 3. Tune in for segments on long COVID and the making of a brain surgeon.
Read More
 
 
 
     
 
 
Sandy receives Daisy Award
Keisha Sandy, RN, BSN, OCN, a unit nurse educator in the infusion center on Winship's Clifton Road campus, has received a Daisy Award, which honors nurses who define patient family care. Sandy was nominated for the award for her outstanding work helping our patients navigate their treatment and receive the best experience possible.
About the Daisy Foundation
 
  
Jansen highlighted among Emory’s best and brightest
Carey Jansen, a cancer biologist and researcher in Emory's MD/PhD program, is featured among 16 of Emory’s best and brightest students. Jansen's research focuses on immune mechanisms in cancer development and treatment, as well as immunotherapy development.
Read More
 
 
 
     
 
 
In memoriam: Robbin Clark
Robbin Clark, a valued member of Winship’s cancer registrar team, passed away on Dec. 1. We offer our deepest condolences to her friends, family, and Winship community.
View Condolence Page
 
  
Winship spaces full of holiday cheer
Winship teams showed off their creativity and holiday spirit this season, transforming offices and clinical areas into winter wonderlands. Pictured: treescapes from Winship's infusion center on the Clifton Road campus.
View More Photos
 
 
 

Below are four selected Winship publications out of 48 published over the past week:
 
 
 

Schneider BP, Jiang G, Ballinger TJ, Shen F, Chitambar C, Nanda R, Falkson C, Lynce FC, Gallagher C, Isaacs C, Blaya M, Paplomata E, Walling R, Daily K, Mahtani R, Thompson MA, Graham R, Cooper ME, Pavlick DC, Albacker LA, Gregg J, Solzak JP, Chen YH, Bales CL, Cantor E, Hancock BA, Kassem N, Helft P, O'Neil B, Storniolo AMV, Badve S, Miller KD, Radovich M. BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer. Journal of Clinical Oncology: official journal of the American Society of Clinical Oncology. 2021; JCO2101657. PubMed PMID: 34910554.
View in PubMed
 
 
 

Yarchoan M, Cope L, Ruggieri AN, Anders RA, Noonan AM, Goff LW, Goyal L, Lacy J, Li D, Patel AK, He AR, Abou-Alfa GK, Spencer K, Kim EJ, Davis SL, McRee AJ, Kunk PR, Goyal S, Liu Y, Dennison L, Xavier S, Mohan AA, Zhu Q, Wang-Gillam A, Poklepovic A, Chen HX, Sharon E, Lesinski GB, Azad NS. Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers. The Journal of Clinical Investigation. 2021; 131(24). PubMed PMID: 34907910.
View in PubMed
 
 
 

Koshkin VS, Henderson N, James M, Natesan D, Freeman D, Nizam A, Su CT, Khaki AR, Osterman CK, Glover MJ, Chiang R, Makrakis D, Talukder R, Lemke E, Olsen TA, Jain J, Jang A, Ali A, Jindal T, Chou J, Friedlander TW, Hoimes C, Basu A, Zakharia Y, Barata PC, Bilen MA, Emamekhoo H, Davis NB, Shah SA, Milowsky MI, Gupta S, Campbell MT, Grivas P, Sonpavde GP, Kilari D, Alva AS. Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study. Cancer. 2021; PubMed PMID: 34882781.
View in PubMed
 
 
 

Forlenza CJ, Gulati N, Mauguen A, Absalon MJ, Castellino SM, Franklin A, Keller FG, Shukla N. Combination brentuximab vedotin and bendamustine for pediatric patients with relapsed/refractory Hodgkin lymphoma. Blood Advances. 2021; 5(24):5519-5524. PubMed PMID: 34559223.
View in PubMed
 
 
 

View More Publications

 
 
 

 
 
 

December 20 - Lung Cancer SPORE Meeting (virtual)
John Heymach, MD, PhD
 
 
 

December 22 & 29 - No Grand Rounds
About Winship Grand Rounds
 
 
 

December 23 & 30 - No Surgical Grand Rounds
About Surgical Grand Rounds
 
 
 

December 24 & 31 - No Elkin Lecture
About Elkin Lectures
 
 
 

 
 
 
     
 
 
Winship Federal Grant Stream
Winship's Federal Grant Stream provides a daily updated list of cancer-related funding from the National Institutes of Health and other agencies.
View Funding Opportunities
 
  
Non-Federal Funding Opportunities
View a selection of Winship pilot grants, institutional awards, and external funding sources and learn how to apply.
View Funding Opportunities
 
 
 

A selection of media stories and news coverage for Winship Cancer Institute.
 
 
 

Read Winship in the News

 
 
 
 
  
 
 

You are receiving Winship Roundup as a member or employee of Winship Cancer Institute. If you wish to unsubscribe, please email Winship Communications.

Emory Home | Emory News Center | Give to Emory | Contact Emory
Have a story for Winship Roundup? Submit your suggestion via email.

© 2021 Winship Cancer Institute of Emory University | 1365 Clifton Rd. NE, Bldg. C, Atlanta, Georgia 30322